In the few cases where ECM components have been targeted before, target proteins such as tumour‐specific variants of the ECM proteins fibronectin and tenascin are primarily located around tumour blood vessels (Borsi et al, 2003; Kim et al, 2012). This evidence concerns the gene TNC and neoplasm.